CRS 2017

44^th Annual Meeting and Exposition of the Controlled Release Society

July 16 - 19, 2017 in Boston, Massachusetts

Visit us at our new, vibrant booth 412

EMD Millipore + Sigma-Aldrich come together as MilliporeSigma to empower you to focus on your work with confidence, to solve the toughest problems in life science. We support our customers with best-in-class products for your lab, combined with technical expertise.

Meet our new MilliporeSigma team at booth 412 and learn about our latest products and complete portfolio for all stages of the drug manufacturing process, from academic R&D to industrial-scale production and quality control. Ask how our newest technologies will improve productivity, lower risks, reduce costs and promote safety. Together with you, MilliporeSigma is advancing bioproduction to accelerate development of therapeutic drugs for patients in need.

Visit the Event Website

Poster presentation topics include:

• Michael Platscher: Solid phase synthesis of active targeting lipids. A versatile, economic and scalable method to manufacture complex lipids for active targeting in high quality
  Display: Monday, July 17; Author Session: 3:30 - 4:00 PM
  Poster Number: 110, Group B
• Günter Moddelmog: Tailoring in-vitro drug release in solid dosage forms – a combination of PVA and HPMC
  Display: Tuesday, July 18; Author Session: 3:30 - 4:00 PM
  Poster Number: 287, Group D
• Günter Moddelmog: One strategy to address both solubility enhancement and controlled release: Polyvinyl alcohol for hot melt extrusion
  Display: Tuesday, July 18; Author Session: 3:30 - 4:00 PM
  Poster Number: 289, Group D
• Prof. Ajay K. Banga: Development of avobenzone microsponge gel formulation using polyvinyl alcohol (Collaborative Poster with Mercer University which features MilliporeSigma excipients)
  Display: Tuesday, July 18; Author Session: 3:30 - 4:00 PM
  Poster Number: 333, Group D

Join our Workshop

Enabling Successful Liposomal Formulation from Scratch – Lipid Synthesis, CMC, Regulatory and Case Study.

Attend our joint premeeting workshop hosted by experts from MilliporeSigma, Polymun Scientific, the FDA, and MiNA Therapeutics. Their presentations will highlight the following topics:

• “Process Development and GMP Manufacturing of Lipids” (Dr. Michael Platscher, MilliporeSigma)
• “Lessons learned from liposomal products and processes - chemistry, manufacturing and controls” (Dr. Andreas Wagner, Polymun Scientific)
• “Driving Biomedical Innovation be Advancing FDA’s Science Alliance” (Dr. Frank Weichold, FDA)
• “Development of a small activating RNA (saRNA) encapsulated in a SMARTICLE® liposomal formulation for treatment of liver disease including Hepatocelluar cancer” (Prof. David Blakey, MiNA Therapeutics)

July 16, 8 AM – 1 PM

At the Sheraton Boston Hotel, which connects directly to the Hynes Convention Center.

Costs: 179 USD